Universal theranostic CRISPR/Cas13a RNA-editing system for glioma.
Wu Y, Wang Y, Zhou J, Wang J, Zhan Q, Wang Q, Yang E, Jin W, Tong F, Zhao J, Hong B, Liu J, Kang C.
Wu Y, et al.
Theranostics. 2023 Sep 25;13(15):5305-5321. doi: 10.7150/thno.84429. eCollection 2023.
Theranostics. 2023.
PMID: 37908718
Free PMC article.
Retracted.